Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively;

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2022 Financial Results BERKELEY HEIGHTS, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...

New Book Reveals Reasons Behind Record-Breaking Employee Dissatisfaction WAYNE, PA--(Marketwire - January 24, 2011) - Kenexa (NASDAQ: KNXA), a global provider of business solutions for human resources, today announced the publication of "We: How to Increase Performance...